Advancing Knowledge,
Improving Patient Outcomes

AcademicCME is a jointly accredited healthcare solutions medical education company designed to impact practice behavior by providing clinicians with multi-format educational resources in various therapeutic areas. Our mission is to improve patient outcomes through practical, customized and comprehensive continuing education.

CE Courses

The New and Emerging Role of Bruton's Tyrosine Kinase Inhibitor (BTKi) Therapeutics to Improve Long-Term Outcomes in Patients with Relapsing Multiple Sclerosis

Program Overview

This CME/CE activity is derived from content presented at the 6th Annual Advanced Curriculum for Multiple Sclerosis 2021 Virtual CME/CE Course. The expert faculty, led by Dr. Fred D. Lublin, will review the science and mode of action for Bruton's Tyrosine Kinase (BTK) inhibitors. The faculty will analyze the role of BTK in microglia and the clinical trial ...
View Course
Advanced Therapeutics in Movement Disorders

Program Overview

This CME program will highlight recent advances in the treatment and management of patients with Parkinson’s disease (PD), covering topics such as OFF episodes, deep brain stimulation (DBS) and psychosis. The expert faculty, led by Dr. Stuart Isaacson, will first delve into OFF episodes, analyzing the causes of OFF periods, and the impact on quality of life and ...
View Course
Addressing Healthcare Disparities and COVID-19 Concerns for All Patients with Multiple Sclerosis

Program Overview

This CME/CE symposium, led by Fred D. Lublin, MD, is derived from content presented at the Virtual ACTRIMS Forum in February, 2021. In this program, the expert faculty will review current disparities for the management of patients across the entire spectrum of disease with multiple sclerosis (MS). The faculty will discuss the immune-science relationship between COVID-19 infections and ...
View Course
Novel Targeted Therapies to Slow Disease Progression in Patients with Early-Stage Alzheimer’s Disease

Program Overview

This CE activity will highlight novel therapies to slow disease progression in patients with early-stage Alzheimer’s disease (AD), including data presented at the Virtual 13th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Digital Conference 2020. The expert faculty, led by Dr. Richard S. Isaacson, will first delve into the pathophysiology, early and accurate differential diagnosis and disease course ...
View Course

Upcoming Events

Eastern Pulmonary Conference 2022

September 8th – 11th, 2022

Congress of Clinical Rheumatology West Meeting

October 20th – 23rd, 2022

ASHP Midyear Clinical Meeting and Exhibition

December 4th – 8th, 2022

The Alliance 2023 Annual Conference

January 11th – 14th, 2023